OpenURL Connection Search

Select item for more details and to access through your institution.

Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis.
Published in:
2022
By:
- Ismail, Rawa Kamaran;
- Breeschoten, Jesper van;
- van der Flier, Silvia;
- Loosen, Caspar van;
- Pasmooij, Anna Maria Gerdina;
- Dartel, Maaike van;
- van den Eertwegh, Alfons;
- Boer, Anthonius de;
- Wouters, Michel;
- Hilarius, Doranne;
- van Breeschoten, Jesper;
- van Loosen, Caspar;
- van Dartel, Maaike;
- de Boer, Anthonius
Publication type:
journal article
Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The Netherlands.
Published in:
Cancers, 2021, v. 13, n. 20, p. 5077, doi. 10.3390/cancers13205077
By:
- van Breeschoten, Jesper;
- van den Eertwegh, Alfonsus J. M.;
- de Wreede, Liesbeth C.;
- Hilarius, Doranne L.;
- van Zwet, Erik W.;
- Haanen, John B.;
- Blank, Christian U.;
- Aarts, Maureen J. B.;
- van den Berkmortel, Franchette W. P. J.;
- de Groot, Jan Willem B.;
- Hospers, Geke A. P.;
- Kapiteijn, Ellen;
- Piersma, Djura;
- van Rijn, Rozemarijn S.;
- Stevense-den Boer, Marion A. M.;
- van der Veldt, Astrid A. M.;
- Vreugdenhil, Gerard;
- Boers-Sonderen, Marye J.;
- Suijkerbuijk, Karijn P. M.;
- Wouters, Michel W. J. M.
Publication type:
Article
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease : A Cohort Study.
Published in:
2021
By:
- van der Kooij, Monique K.;
- Suijkerbuijk, Karijn P.M.;
- Aarts, Maureen J.B.;
- van den Berkmortel, Franchette W.P.J.;
- Blank, Christian U.;
- Boers-Sonderen, Marye J.;
- van Breeschoten, Jesper;
- van den Eertwegh, Alfonsus J.M.;
- de Groot, Jan Willem B.;
- Haanen, John B.A.G.;
- Hospers, Geke A.P.;
- Piersma, Djura;
- van Rijn, Rozemarijn S.;
- ten Tije, Albert J.;
- van der Veldt, Astrid A.M.;
- Vreugdenhil, Gerard;
- van Zeijl, Michiel C.T.;
- Wouters, Michel W.J.M;
- Dekkers, Olaf M.;
- Kapiteijn, Ellen
Publication type:
journal article
The unfavorable effects of COVID‐19 on Dutch advanced melanoma care.
Published in:
International Journal of Cancer, 2022, v. 150, n. 5, p. 816, doi. 10.1002/ijc.33833
By:
- van Not, Olivier J.;
- van Breeschoten, Jesper;
- van den Eertwegh, Alfonsus J. M.;
- Hilarius, Doranne L.;
- De Meza, Melissa M.;
- Haanen, John B.;
- Blank, Christian U.;
- Aarts, Maureen J. B.;
- van den Berkmortel, Franchette W. P. J.;
- de Groot, Jan Willem B.;
- Hospers, Geke A. P.;
- Ismail, Rawa K.;
- Kapiteijn, Ellen;
- Piersma, Djura;
- van Rijn, Rozemarijn S.;
- Stevense‐den Boer, Marion A. M.;
- van der Veldt, Astrid A. M.;
- Vreugdenhil, Gerard;
- Boers‐Sonderen, Marye J.;
- Blokx, Willeke A. M.
Publication type:
Article
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.
Published in:
2022
By:
- van Breeschoten, Jesper;
- Wouters, Michel W. J. M.;
- Hilarius, Doranne L.;
- Haanen, John B.;
- Blank, Christian U.;
- Aarts, Maureen J. B.;
- van den Berkmortel, Franchette W. P. J.;
- de Groot, Jan-Willem B.;
- Hospers, Geke A. P.;
- Kapiteijn, Ellen;
- Piersma, Djura;
- van Rijn, Roos S.;
- Suijkerbuijk, Karijn P. M.;
- Blokx, Willeke A. M.;
- Tije, Bert-Jan J. ten;
- Veldt, Astrid A. M. van der;
- Vreugdenhil, Art;
- Boers-Sonderen, Marye J.;
- van den Eertwegh, Alfonsus J. M.
Publication type:
corrected article
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.
Published in:
2021
By:
- van Breeschoten, Jesper;
- Wouters, Michel W. J. M.;
- Hilarius, Doranne L.;
- Haanen, John B.;
- Blank, Christian U.;
- Aarts, Maureen J. B.;
- van den Berkmortel, Franchette W. P. J.;
- de Groot, Jan-Willem B.;
- Hospers, Geke A. P.;
- Kapiteijn, Ellen;
- Piersma, Djura;
- van Rijn, Roos S.;
- Suijkerbuijk, Karijn P. M.;
- Blokx, Willeke A. M.;
- ten Tije, Bert-Jan J.;
- van der Veldt, Astrid A. M.;
- Vreugdenhil, Art;
- Boers-Sonderen, Marye J.;
- van den Eertwegh, Alfonsus J. M.
Publication type:
corrected article
First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.
Published in:
2021
By:
- van Breeschoten, Jesper;
- Wouters, Michel W. J. M.;
- Hilarius, Doranne L.;
- Haanen, John B.;
- Blank, Christian U.;
- Aarts, Maureen J. B.;
- van den Berkmortel, Franchette W. P. J.;
- de Groot, Jan-Willem B.;
- Hospers, Geke A. P.;
- Kapiteijn, Ellen;
- Piersma, Djura;
- van Rijn, Roos S.;
- Suijkerbuijk, Karijn P. M.;
- Blokx, Willeke A. M.;
- Tije, Bert-Jan J. ten;
- Veldt, Astrid A. M. van der;
- Vreugdenhil, Art;
- Boers-Sonderen, Marye J.;
- van den Eertwegh, Alfonsus J. M.
Publication type:
journal article
Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer.
Published in:
JAMA Network Open, 2021, v. 4, n. 9, p. e2124766, doi. 10.1001/jamanetworkopen.2021.24766
By:
- van Nassau, Sietske C.;
- Bond, Marinde J.;
- Scheerman, Ilva;
- van Breeschoten, Jesper;
- Kessels, Rob;
- Valkenburg-van Iersel, Liselot B.;
- Verheul, Henk M.;
- Buffart, Tineke E.;
- Mekenkamp, Leonie J.;
- Lemmens, Valery E.;
- Koopman, Miriam;
- Bol, Guus M.
Publication type:
Article

Found: 8

Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis.

Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The Netherlands.

Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease : A Cohort Study.

The unfavorable effects of COVID‐19 on Dutch advanced melanoma care.

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.

First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.

Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer.